MA28117A1 - Procédé pour la préparation de composés hétérocycliques à substitution N-amino - Google Patents
Procédé pour la préparation de composés hétérocycliques à substitution N-aminoInfo
- Publication number
- MA28117A1 MA28117A1 MA28977A MA28977A MA28117A1 MA 28117 A1 MA28117 A1 MA 28117A1 MA 28977 A MA28977 A MA 28977A MA 28977 A MA28977 A MA 28977A MA 28117 A1 MA28117 A1 MA 28117A1
- Authority
- MA
- Morocco
- Prior art keywords
- propylidene
- amine
- indol
- hydrogen
- integer
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- NZVNTPKKKIVEOY-UHFFFAOYSA-N n-(1h-carbazol-1-yl)propan-1-imine Chemical compound C1=CC=C2C3=CC=CC(N=CCC)C3=NC2=C1 NZVNTPKKKIVEOY-UHFFFAOYSA-N 0.000 abstract 1
- HAPDTGGOWRVVKA-UHFFFAOYSA-N n-(3-methylindol-1-yl)propan-1-imine Chemical compound C1=CC=C2N(N=CCC)C=C(C)C2=C1 HAPDTGGOWRVVKA-UHFFFAOYSA-N 0.000 abstract 1
- PIEUYICYHSQDHD-UHFFFAOYSA-N n-(5-methoxyindol-1-yl)propan-1-imine Chemical compound COC1=CC=C2N(N=CCC)C=CC2=C1 PIEUYICYHSQDHD-UHFFFAOYSA-N 0.000 abstract 1
- WHWBGXUEVLJPSC-UHFFFAOYSA-N n-(5-phenylmethoxyindol-1-yl)propan-1-imine Chemical compound C=1C=C2N(N=CCC)C=CC2=CC=1OCC1=CC=CC=C1 WHWBGXUEVLJPSC-UHFFFAOYSA-N 0.000 abstract 1
- BHUWZHNCPCFHCU-UHFFFAOYSA-N n-indol-1-ylpropan-1-imine Chemical compound C1=CC=C2N(N=CCC)C=CC2=C1 BHUWZHNCPCFHCU-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Ceramic Engineering (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Structural Engineering (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
fluoroalkyle ou un fluoroalcoxy de formule CnHxFy ou OCnHxFy où n est un nombre entier de 1 à 4, x est un nombre entier de 0 à 8, y est un nombre entier de 1 à 9 et la somme de x et y vaut 2n+l ; ou R1 et R2 pris ensemble avec les atomes de carbone auxquels ils sont attachés forment un noyau cyclique en Cs-Cg; R3 et R4 sont identiques ou différents et sont chacun indépendamment sélectionnés parmi un hydrogène ou un alkyle en C1-C4; et m vaut 1 ou 2; ou un énantiomère, un stéréoisomère ou un mélange de ceux-ci, un tautomère de celui-ci ou un sel pharmaceutiquement acceptable, un solvate ou un dérivé de celui-ci; à condition que lorsque R et R3 sont un hydrogène, R4 ne soit pas un hydrogène ou un methyle. 54. Composé suivant la revendication 53, dans lequel R, Ri et R3 sont un hydrogène et R2 est un méthyle. 55. Composé suivant la revendication 53, qui est sélectionné parmi le groupe comprenant : la 3 méthyl-N-(propylidène)-lH-indol-l-amine; la N-(propylidène)-l H-indol-1-amine; la 5-benzyloxy-N-(propylidène)-l H-indol-1-amine; 2 5 la 5 -méthoxy-N-(propylidène)-1 H-indol-1-amine; et la N-(propylidène)-1 H-carbazol-1-amine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50833503P | 2003-10-03 | 2003-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA28117A1 true MA28117A1 (fr) | 2006-08-01 |
Family
ID=34434904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28977A MA28117A1 (fr) | 2003-10-03 | 2006-04-28 | Procédé pour la préparation de composés hétérocycliques à substitution N-amino |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7112682B2 (fr) |
| EP (1) | EP1678135B1 (fr) |
| JP (1) | JP2007507518A (fr) |
| KR (1) | KR20060120028A (fr) |
| CN (2) | CN100579963C (fr) |
| AR (1) | AR046041A1 (fr) |
| AT (1) | ATE431339T1 (fr) |
| AU (1) | AU2004279808B2 (fr) |
| BR (1) | BRPI0415002A (fr) |
| CA (1) | CA2540867A1 (fr) |
| DE (1) | DE602004021126D1 (fr) |
| DK (1) | DK1678135T3 (fr) |
| ES (1) | ES2327417T3 (fr) |
| HR (2) | HRP20090441T1 (fr) |
| IL (1) | IL174238A0 (fr) |
| MA (1) | MA28117A1 (fr) |
| ME (1) | MEP19508A (fr) |
| MX (1) | MXPA06003446A (fr) |
| NO (1) | NO20061929L (fr) |
| NZ (1) | NZ545838A (fr) |
| PL (1) | PL1678135T3 (fr) |
| PT (1) | PT1678135E (fr) |
| RS (1) | RS20060225A (fr) |
| RU (1) | RU2364588C2 (fr) |
| SI (1) | SI1678135T1 (fr) |
| TW (1) | TW200519086A (fr) |
| WO (1) | WO2005035496A1 (fr) |
| ZA (1) | ZA200602694B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040132708A1 (en) * | 2002-05-01 | 2004-07-08 | Wyeth | Process for preparing 6-alkylidene penem derivatives |
| AR039476A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | Proceso para preparar derivados de 6-alquiliden penem |
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| US7538227B2 (en) * | 2004-01-13 | 2009-05-26 | Sanofi-Aventis Deutschland Gmbh | Process for stabilizing 4-halopyridines |
| WO2006115456A1 (fr) * | 2005-04-26 | 2006-11-02 | Cambrex Karlskoga Ab | Synthese de la 1-aminopiperidine |
| GT200600332A (es) * | 2005-07-27 | 2007-03-14 | Inhibidores de 6-alquiliden-penem beta-lactamasa triciclicos y combinación de antibióticos de b-lactama: un antibiotico de amplio espectro | |
| BRPI0613927A2 (pt) * | 2005-07-27 | 2011-02-15 | Wyeth Corp | uso de cefepima ou um sal farmaceuticamente aceitável desta e um composto da fórmula i ou um sal farmaceuticamente aceitável ou éster deste hidrolisável in vivo; composição; embalagem; e produto |
| GT200600380A (es) * | 2005-08-24 | 2007-03-29 | Proceso para la preparacion de inhibidores de beta-lactamasa | |
| FR2897614B1 (fr) * | 2006-02-20 | 2008-05-23 | Urogene | Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations |
| ES2539365T3 (es) | 2009-10-30 | 2015-06-30 | President And Fellows Of Harvard College | Compuestos de 2-aminoindol y métodos para el tratamiento de la malaria |
| CN105753838A (zh) * | 2016-02-11 | 2016-07-13 | 安阳师范学院 | 喹啉衍生物高区域选择性胺化新方法 |
| WO2018207904A1 (fr) * | 2017-05-12 | 2018-11-15 | 中外製薬株式会社 | Procédé de production d'un composé organique cyclique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0629273B2 (ja) | 1986-06-13 | 1994-04-20 | 宇部興産株式会社 | Ｎ−アミノヘキサメチレンイミンの製造法 |
| JPH01157922A (ja) | 1987-12-15 | 1989-06-21 | Citizen Watch Co Ltd | ニトリル化合物の製造方法 |
| US5459274A (en) * | 1994-05-13 | 1995-10-17 | Hoechst-Roussel Pharmaceuticals Inc. | Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines |
-
2004
- 2004-09-30 AR ARP040103557A patent/AR046041A1/es not_active Application Discontinuation
- 2004-10-01 DE DE602004021126T patent/DE602004021126D1/de not_active Expired - Lifetime
- 2004-10-01 CA CA002540867A patent/CA2540867A1/fr not_active Abandoned
- 2004-10-01 RS RSP-2006/0225A patent/RS20060225A/sr unknown
- 2004-10-01 ME MEP-195/08A patent/MEP19508A/xx unknown
- 2004-10-01 HR HR20090441T patent/HRP20090441T1/xx unknown
- 2004-10-01 PL PL04785294T patent/PL1678135T3/pl unknown
- 2004-10-01 AU AU2004279808A patent/AU2004279808B2/en not_active Ceased
- 2004-10-01 EP EP04785294A patent/EP1678135B1/fr not_active Expired - Lifetime
- 2004-10-01 DK DK04785294T patent/DK1678135T3/da active
- 2004-10-01 BR BRPI0415002-3A patent/BRPI0415002A/pt not_active IP Right Cessation
- 2004-10-01 CN CN200480035790A patent/CN100579963C/zh not_active Expired - Fee Related
- 2004-10-01 TW TW093129738A patent/TW200519086A/zh unknown
- 2004-10-01 US US10/957,124 patent/US7112682B2/en not_active Expired - Lifetime
- 2004-10-01 PT PT04785294T patent/PT1678135E/pt unknown
- 2004-10-01 AT AT04785294T patent/ATE431339T1/de not_active IP Right Cessation
- 2004-10-01 MX MXPA06003446A patent/MXPA06003446A/es active IP Right Grant
- 2004-10-01 NZ NZ545838A patent/NZ545838A/en unknown
- 2004-10-01 JP JP2006534079A patent/JP2007507518A/ja not_active Abandoned
- 2004-10-01 SI SI200431204T patent/SI1678135T1/sl unknown
- 2004-10-01 CN CNA2008101707936A patent/CN101391976A/zh active Pending
- 2004-10-01 RU RU2006114667/04A patent/RU2364588C2/ru not_active IP Right Cessation
- 2004-10-01 KR KR1020067006835A patent/KR20060120028A/ko not_active Ceased
- 2004-10-01 WO PCT/US2004/032086 patent/WO2005035496A1/fr not_active Ceased
- 2004-10-01 ES ES04785294T patent/ES2327417T3/es not_active Expired - Lifetime
- 2004-10-01 HR HR20060124A patent/HRP20060124A2/xx not_active Application Discontinuation
-
2006
- 2006-03-09 IL IL174238A patent/IL174238A0/en unknown
- 2006-03-31 ZA ZA200602694A patent/ZA200602694B/en unknown
- 2006-04-28 MA MA28977A patent/MA28117A1/fr unknown
- 2006-04-28 NO NO20061929A patent/NO20061929L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA28117A1 (fr) | Procédé pour la préparation de composés hétérocycliques à substitution N-amino | |
| RU95108329A (ru) | Замещенные производные тиазолидиндиона, способ их получения, фармкомпозиция | |
| EP0264231A1 (fr) | Dérivés de l'azétidinone | |
| ES2121441T3 (es) | Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco | |
| JPH0748372A (ja) | 医薬組成物 | |
| HUP0004926A2 (hu) | A fenilgyűrű 2-helyzetében helyettesített 1-(N-fenilaminoalkil)piperazin-származékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| EA200601235A1 (ru) | Производные тиазола | |
| HUP9900949A2 (hu) | Triazolilcsoportot tartalmazó foszfátok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| US4234584A (en) | Substituted phenylpiperazine derivatives | |
| RU2002107318A (ru) | Новые фенилпиперазины | |
| KR950701323A (ko) | 1-피페라지노-1,2-디히드로인덴 유도체(1-Piperazino-1,2-dihydroindene Derivatives) | |
| MA41790B1 (fr) | Dérivé de morphinane | |
| HUT53099A (en) | Process for producing new tetrahydrobenzimidazole derivatives and pharmaceutical compositions comprising such compounds | |
| MA35113B1 (fr) | 5-(phényl/pyridinyl-éthinyl)-2-pyridine/2 pyrimidine-carboxamides comme modulateur de mglur5 | |
| KR920016454A (ko) | 환-치환된 2-아미노-1,2,3,4-테트라하이드로나프탈렌 및 3-아미노크로만 | |
| CA2382247A1 (fr) | Azaindoles possedant une affinite pour le recepteur de serotonine | |
| US3328390A (en) | Certain azabicycloalkane compounds | |
| NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
| FR2471381A1 (fr) | Derives de l'ergoline, procede pour les preparer et leur emploi comme medicaments | |
| FR2858321B1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| YU52498A (sh) | UPOTREBA 2-ARILBENZO (b) TIOFENA ZA DOBIJANJE LEKA | |
| EA200401077A1 (ru) | 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b | |
| GB1169945A (en) | Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives | |
| US4499090A (en) | N-(5-aminomethyl-2-oxazolin-2-yl)-N'-phenylureas, compositions and use | |
| CO5180624A1 (es) | Antagonistas muscarinicos |